secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoodRx Holdings, Inc. (GDRX)
CIK:        0001809519
Form:       8-K
Filed at:   2023-06-27T23:59:59+00:00
Accession:  0001193125-23-176254
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

GoodRx CMO Babak Azad to depart July 7; Andrew Slutsky named as replacement
---------------------------------------------------------------------------

- Babak Azad will cease as Chief Marketing Officer effective July 7, 2023.
- Andrew Slutsky, currently SVP of Strategic Marketing Innovation, assumes updated CMO role.
- Slutsky's role will focus on specific marketing programs and initiatives.
- Company expects to enter a Separation Agreement with Azad; terms to be disclosed later.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809519/000119312523176254/0001193125-23-176254-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809519/000119312523176254/d293277d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-176254

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer